期刊论文详细信息
Медицинский совет | 卷:0 |
Experience of using Afobazole in the treatment of pathological anxiety in general practice | |
T. E. Nikitina1  I. N. Agamamedova1  | |
[1] Moscow Research Institute of Psychiatry, Russia's Ministry of Health; | |
关键词: тревожные расстройства; селективные анксиолитики; афобазол; anxiety disorders; selective anxiolytics; afobazole; | |
DOI : 10.21518/2079-701X-2014-5-70-73 | |
来源: DOAJ |
【 摘 要 】
The effect of daily 30 mg dose of Afobazole was evaluated in 35 patients (26 women and 9 men) aged 18 to 60 years (mean age 44.7 years) with pathological anxiety. By the end of week 4 therapeutic remission was observed in 68.6% of patients: marked improvement in 22.9% of patients, and moderate improvement in 45.7% of patients. Afobazole therapy was not generally accompanied by side effects or sedation allowing patients to maintain usual daily activities and contributed to high level of adherence.
【 授权许可】
Unknown